{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["59(8)"],"submitter":["Ghamry M"],"pubmed_abstract":["Rice bran was fermented with <i>Lactobacillus apis,</i> isolated from the bee gut as a novel probiotic strain, and <i>Saccharomyces cerevisiae</i> to investigate the relationship between its metabolites and antioxidant activity, nutraceutical value, and cytotoxic activity against the HT-29 cell line. The findings showed that <i>L. apis</i> improved the antioxidant activity (DPPH of 37.73%) and antioxidant capacity (ABTS of 37.62 mg Trolox/g,), as well as, hydroxyl radical-scavenging activity (91.55%) of rice bran compared to <i>S. cerevisiae.</i> The metabolic analysis of volatile compounds revealed an increase of alcohols and lactones in the samples fermented with <i>S. cerevisiae</i>. While the samples fermented with <i>L. apis</i> displayed an increase of ketones, esters, and thiazoles. On the other hand, <i>L. apis</i> and <i>S. cerevisiae</i> exhibited a significant ability to increase γ-aminobutyric acid during different fermentation times. Compared with non-fermented samples (18.54%), <i>L. apis</i> increased the cytotoxic activity of rice bran against the HT-29 cell line to 34.17%, and <i>S. cerevisiae</i> to 31.34%. These results suggest that the fermentation of rice bran with <i>S. cerevisiae</i> and <i>L. apis</i> provides a promising strategy to improve the antioxidant activity and nutraceuticals of rice bran, and a potential source for plant-based pharmaceutical products.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1007/s13197-022-05512-2."],"journal":["Journal of food science and technology"],"pagination":["3031-3042"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9304478"],"repository":["biostudies-literature"],"pubmed_title":["Impact of a novel probiotic <i>Lactobacillus</i> strain isolated from the bee gut on GABA content, antioxidant activity, and potential cytotoxic activity against HT-29 cell line of rice bran."],"pmcid":["PMC9304478"],"pubmed_authors":["Al-Maqtqri QA","Ghamry M","Zhao W","Ghazal AF","Li L"],"additional_accession":[]},"is_claimable":false,"name":"Impact of a novel probiotic <i>Lactobacillus</i> strain isolated from the bee gut on GABA content, antioxidant activity, and potential cytotoxic activity against HT-29 cell line of rice bran.","description":"Rice bran was fermented with <i>Lactobacillus apis,</i> isolated from the bee gut as a novel probiotic strain, and <i>Saccharomyces cerevisiae</i> to investigate the relationship between its metabolites and antioxidant activity, nutraceutical value, and cytotoxic activity against the HT-29 cell line. The findings showed that <i>L. apis</i> improved the antioxidant activity (DPPH of 37.73%) and antioxidant capacity (ABTS of 37.62 mg Trolox/g,), as well as, hydroxyl radical-scavenging activity (91.55%) of rice bran compared to <i>S. cerevisiae.</i> The metabolic analysis of volatile compounds revealed an increase of alcohols and lactones in the samples fermented with <i>S. cerevisiae</i>. While the samples fermented with <i>L. apis</i> displayed an increase of ketones, esters, and thiazoles. On the other hand, <i>L. apis</i> and <i>S. cerevisiae</i> exhibited a significant ability to increase γ-aminobutyric acid during different fermentation times. Compared with non-fermented samples (18.54%), <i>L. apis</i> increased the cytotoxic activity of rice bran against the HT-29 cell line to 34.17%, and <i>S. cerevisiae</i> to 31.34%. These results suggest that the fermentation of rice bran with <i>S. cerevisiae</i> and <i>L. apis</i> provides a promising strategy to improve the antioxidant activity and nutraceuticals of rice bran, and a potential source for plant-based pharmaceutical products.<h4>Supplementary information</h4>The online version contains supplementary material available at 10.1007/s13197-022-05512-2.","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Aug","modification":"2025-04-04T20:07:16.972Z","creation":"2025-04-04T20:07:16.972Z"},"accession":"S-EPMC9304478","cross_references":{"pubmed":["35872742"],"doi":["10.1007/s13197-022-05512-2"]}}